Supplementary Data from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
Authors:
- Tom van Den EndeTETom van Den Ende
- Nicolien C. de ClercqNCNicolien C. de Clercq
- Mark I. van Berge HenegouwenMark I. van Berge Henegouwen
- Suzanne S. GisbertzSGSuzanne S. Gisbertz
- E.D. GeijsenEGE.D. Geijsen
- R.H.A. VerhoevenRVR.H.A. Verhoeven
- Sybren L. MeijerSMSybren L. Meijer
- Sandor SchokkerSSSandor Schokker
- M.P.G. DingsMDM.P.G. Dings
- Jacques J.G.H.M. BergmanJBJacques J.G.H.M. Bergman
- Nadia Haj MohammadNMNadia Haj Mohammad
- Jelle P. RuurdaJRJelle P. Ruurda
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)